Attention deficit hyperactivity disorder in children.
Pritchard
Deborah
D
Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK.
D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000628:therapy; D002648:Child; D003000:Clonidine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D011613:Psychotherapy
D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride; D003000:Clonidine; D003913:Dextroamphetamine